Article ID,Publication Year,Reference,US$/QALY *,Ratio Description,PubMed ID,Target Population,Intervention Description,Title,Comparator Description,Impact
2020-01-34196,2020,Chew 2020 Int J Stroke,32000,"implantable loop recorder VERSUS Standard/Usual Care- conventional monitoring (24- to 48- hour Holter) IN Specific disease- cryptogenic stroke; Age- 41 to 64 years; Gender- Both; Country- Canada; Other- hospital presentation with acute stroke or transient ichemic attack, no prior documentation of atrial fibrillation, additional cardiac monitoring would be needed to screen for paroxysmal atrial fibrillation.",33232196,"Specific disease- cryptogenic stroke; Age- 41 to 64 years; Gender- Both; Country- Canada; Other- hospital presentation with acute stroke or transient ichemic attack, no prior documentation of atrial fibrillation, additional cardiac monitoring would be needed to screen for paroxysmal atrial fibrillation.",implantable loop recorder,Economic evaluation of extended electrocardiogram monitoring for atrial fibrillation  in patients with cryptogenic stroke.,Standard/Usual Care- conventional monitoring (24- to 48- hour Holter),NE
2020-01-34178,2020,Agarwal 2020 BMJ Open,2400,"chronic disease prevention/health promotion program VERSUS Standard/Usual Care- standard/usual care IN Healthy; Age- 41 to 64 years, >=65 years; Gender- Both; Country- Canada; Other- low-income seniors, in subsidized/social housing in five communities across Ontario, Canada.",33109643,"Healthy; Age- 41 to 64 years, >=65 years; Gender- Both; Country- Canada; Other- low-income seniors, in subsidized/social housing in five communities across Ontario, Canada.",chronic disease prevention/health promotion program,Cost-effectiveness analysis of a community paramedicine programme for low-income  seniors living in subsidised housing: the community paramedicine at clinic programme  (CP@clinic).,Standard/Usual Care- standard/usual care,NE
2020-01-34082,2020,Sankar 2020 Anesthesiology,1700,stop-bang + polysomnography VERSUS None IN Specific disease- obstructive sleep apnea; Age- Adult; Gender- Both; Country- Canada; Other- underwent elective inpatient noncardiac surgery.,32930728,Specific disease- obstructive sleep apnea; Age- Adult; Gender- Both; Country- Canada; Other- underwent elective inpatient noncardiac surgery.,stop-bang + polysomnography,Cost-effectiveness Analysis of Preoperative Screening Strategies for Obstructive  Sleep Apnea among Patients Undergoing Elective Inpatient Surgery.,None,NE
2020-01-34082,2020,Sankar 2020 Anesthesiology,2700,stop-bang + portable monitor VERSUS None IN Specific disease- obstructive sleep apnea; Age- Adult; Gender- Both; Country- Canada; Other- underwent elective inpatient noncardiac surgery.,32930728,Specific disease- obstructive sleep apnea; Age- Adult; Gender- Both; Country- Canada; Other- underwent elective inpatient noncardiac surgery.,stop-bang + portable monitor,Cost-effectiveness Analysis of Preoperative Screening Strategies for Obstructive  Sleep Apnea among Patients Undergoing Elective Inpatient Surgery.,None,NE
2020-01-34082,2020,Sankar 2020 Anesthesiology,Dominated,stop-bang alone VERSUS stop-bang + polysomnography IN Specific disease- obstructive sleep apnea; Age- Adult; Gender- Both; Country- Canada; Other- undergoing elective inpatient noncardiac surgery.,32930728,Specific disease- obstructive sleep apnea; Age- Adult; Gender- Both; Country- Canada; Other- undergoing elective inpatient noncardiac surgery.,stop-bang alone,Cost-effectiveness Analysis of Preoperative Screening Strategies for Obstructive  Sleep Apnea among Patients Undergoing Elective Inpatient Surgery.,stop-bang + polysomnography,NW
2020-01-34067,2020,Abu-Raya 2020 CMAJ Open,34000,"pertussis vaccination for pregnant women VERSUS None IN Specific disease- pertussis; Age- 0 to 18 years, Adult; Gender- Both; Country- Canada; Other- infants and pregnant women.",33077536,"Specific disease- pertussis; Age- 0 to 18 years, Adult; Gender- Both; Country- Canada; Other- infants and pregnant women.",pertussis vaccination for pregnant women,Pertussis vaccination in pregnancy in Canada: a cost-utility analysis.,None,NE
2020-01-34032,2020,Maser 2020 Pediatr Blood Cancer,Cost-Saving,"levofloxacin prophylaxis VERSUS Standard/Usual Care- no prophylaxis IN Specific disease- acute lymphocytic leukemia; Age- 0 to 18 years, 19 to 40 years; Gender- Both; Country- Canada.",32785971,"Specific disease- acute lymphocytic leukemia; Age- 0 to 18 years, 19 to 40 years; Gender- Both; Country- Canada.",levofloxacin prophylaxis,Levofloxacin prophylaxis in hospitalized children with leukemia: A cost-utility  analysis.,Standard/Usual Care- no prophylaxis,SE
2020-01-33718,2020,Johnston 2020 J. Med. Econ.,Cost-Saving,abobotulinumtoxina VERSUS onabotulinumtoxina IN Specific disease- pediatric lower limb spasticity; Age- 0 to 18 years; Gender- Both; Country- Canada.,0,Specific disease- pediatric lower limb spasticity; Age- 0 to 18 years; Gender- Both; Country- Canada.,abobotulinumtoxina,Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada.,onabotulinumtoxina,SE
2020-01-33706,2020,Perdrizet 2020 Int. J. Radiat. Oncol. Biol. Phys.,1200,"mri guided brachytherapy VERSUS computed tomography guided brachytherapy IN Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IB to IIA (low-risk) cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",0,"Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IB to IIA (low-risk) cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",mri guided brachytherapy,A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.,computed tomography guided brachytherapy,NE
2020-01-33706,2020,Perdrizet 2020 Int. J. Radiat. Oncol. Biol. Phys.,Cost-Saving,"mri guided brachytherapy VERSUS 2-dimensional image guided brachytherapy IN Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IB to IIA (low-risk) cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",0,"Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IB to IIA (low-risk) cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",mri guided brachytherapy,A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.,2-dimensional image guided brachytherapy,SE
2020-01-33706,2020,Perdrizet 2020 Int. J. Radiat. Oncol. Biol. Phys.,Cost-Saving,"mri guided brachytherapy VERSUS 2-dimensional image guided brachytherapy IN Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IB to IIIB cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",0,"Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IB to IIIB cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",mri guided brachytherapy,A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.,2-dimensional image guided brachytherapy,SE
2020-01-33706,2020,Perdrizet 2020 Int. J. Radiat. Oncol. Biol. Phys.,Cost-Saving,"mri guided brachytherapy VERSUS 2-dimensional image guided brachytherapy IN Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IIB to IIIB (high-risk) cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",0,"Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IIB to IIIB (high-risk) cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",mri guided brachytherapy,A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.,2-dimensional image guided brachytherapy,SE
2020-01-33706,2020,Perdrizet 2020 Int. J. Radiat. Oncol. Biol. Phys.,Cost-Saving,"mri guided brachytherapy VERSUS computed tomography guided brachytherapy IN Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IB to IIIB cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",0,"Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IB to IIIB cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",mri guided brachytherapy,A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.,computed tomography guided brachytherapy,SE
2020-01-33706,2020,Perdrizet 2020 Int. J. Radiat. Oncol. Biol. Phys.,Cost-Saving,"mri guided brachytherapy VERSUS computed tomography guided brachytherapy IN Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IIB to IIIB (high-risk) cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",0,"Specific disease- cervical cancer; Age- 41 to 64 years; Gender- Female; Country- Canada; Other- FIGO stage IIB to IIIB (high-risk) cervical cancer treated with curative-intent external beam radiation, cisplatin followed by brachytherapy.",mri guided brachytherapy,A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.,computed tomography guided brachytherapy,SE
2020-01-33680,2020,Kumar 2020 Clin Otolaryngol,Cost-Saving,"endoscopic polypectomy VERSUS endoscopic sinus surgery IN Specific disease- chronic rhinosinusitis; Age- Adult; Gender- Both; Country- Canada; Other- nasal polyps, bilateral nasal obstruction.",0,"Specific disease- chronic rhinosinusitis; Age- Adult; Gender- Both; Country- Canada; Other- nasal polyps, bilateral nasal obstruction.",endoscopic polypectomy,Cost-effectiveness of Endoscopic Polypectomy in Clinic compared to Endoscopic Sinus Surgery: A modelling study.,endoscopic sinus surgery,SE
2020-01-33568,2020,Beaupre 2020 Arch. Osteoporosis,5500,"hip fracture liason service VERSUS Standard/Usual Care- usual hip fracture care IN Specific disease- hip fracture; Age- 41 to 64 years, >=65 years; Gender- Both; Country- Canada.",0,"Specific disease- hip fracture; Age- 41 to 64 years, >=65 years; Gender- Both; Country- Canada.",hip fracture liason service,A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical program.,Standard/Usual Care- usual hip fracture care,NE
2020-01-33497,2020,Turner 2020 J. Gerontol. A Biol. Sci. Med. Sci.,Cost-Saving,"pharmacist-led patient and primary care giver education for discontinuation of sedative medications VERSUS Standard/Usual Care- standard/usual care IN Healthy; Age- >=65 years; Gender- Both; Country- Canada; Other- community dwelling, chronic users of sedatives for management of insomnia.",0,"Healthy; Age- >=65 years; Gender- Both; Country- Canada; Other- community dwelling, chronic users of sedatives for management of insomnia.",pharmacist-led patient and primary care giver education for discontinuation of sedative medications,Economic Evaluation of Sedative Deprescribing in Older Adults by Community Pharmacists.,Standard/Usual Care- standard/usual care,SE
2020-01-33495,2020,Gosselin-Tardif 2020 BJS Open,15000,laparoscopic subtotal gastrectomy VERSUS open subtotal gastrectomy IN Specific disease- gastric adenocarcinoma; Age- Adult; Gender- Both; Country- Canada.,0,Specific disease- gastric adenocarcinoma; Age- Adult; Gender- Both; Country- Canada.,laparoscopic subtotal gastrectomy,Laparoscopic versus open subtotal gastrectomy for gastric adenocarcinoma: cost-effectiveness analysis.,open subtotal gastrectomy,NE
2020-01-33492,2020,Meng 2020 J. Neurosurg.,22000,mr-guided focused ultrasound + continued medical therapy VERSUS Standard/Usual Care- medical therapy alone IN Specific disease- parkinson's disease; Age- Adult; Gender- Both; Country- Canada; Other- tremor-dominant.,0,Specific disease- parkinson's disease; Age- Adult; Gender- Both; Country- Canada; Other- tremor-dominant.,mr-guided focused ultrasound + continued medical therapy,Cost-effectiveness analysis of MR-guided focused ultrasound thalamotomy for tremor-dominant Parkinson''s disease.,Standard/Usual Care- medical therapy alone,NE
2020-01-33492,2020,Meng 2020 J. Neurosurg.,42000,deep brain stimulation VERSUS mr-guided focused ultrasound IN Specific disease- parkinson's disease; Age- Adult; Gender- Both; Country- Canada; Other- tremor-dominant.,0,Specific disease- parkinson's disease; Age- Adult; Gender- Both; Country- Canada; Other- tremor-dominant.,deep brain stimulation,Cost-effectiveness analysis of MR-guided focused ultrasound thalamotomy for tremor-dominant Parkinson''s disease.,mr-guided focused ultrasound,NE
1 2 3 4 5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
